143 related articles for article (PubMed ID: 8899871)
1. Localization of type II phospholipase A2 messenger RNA and immunoactivity in human placenta and fetal membranes.
Aitken MA; Thomas T; Brennecke SP; Scott KF; Rice GE
Placenta; 1996 Sep; 17(7):423-9. PubMed ID: 8899871
[TBL] [Abstract][Full Text] [Related]
2. Secretory type II PLA2 immunoreactivity and PLA2 enzymatic activity in human gestational tissues before, during and after spontaneous-onset labour at term.
Munns MJ; Farrugia W; King RG; Rice GE
Placenta; 1999 Jan; 20(1):21-6. PubMed ID: 9950141
[TBL] [Abstract][Full Text] [Related]
3. Differential expression of type II, IV and cytosolic PLA2 messenger RNA in human intrauterine tissues at term.
Freed KA; Moses EK; Brennecke SP; Rice GE
Mol Hum Reprod; 1997 Jun; 3(6):493-9. PubMed ID: 9239738
[TBL] [Abstract][Full Text] [Related]
4. Type II phospholipase A2 in human gestational tissues: extractable immuno- and enzymatic activity in fetal membranes.
Aitken MA; Farrugia W; Wong MH; Scott KF; Brennecke SP; Rice GE
Biochim Biophys Acta; 1993 Nov; 1170(3):314-20. PubMed ID: 8218351
[TBL] [Abstract][Full Text] [Related]
5. Differential expression of 11 beta-hydroxysteroid dehydrogenase types 1 and 2 in human placenta and fetal membranes.
Sun K; Yang K; Challis JR
J Clin Endocrinol Metab; 1997 Jan; 82(1):300-5. PubMed ID: 8989277
[TBL] [Abstract][Full Text] [Related]
6. Distribution of the phospholipase A2 receptor messenger RNA in human gestational tissues.
Moses EK; Freed KA; Brennecke SP; Rice GE
Placenta; 1998 Jan; 19(1):35-40. PubMed ID: 9481783
[TBL] [Abstract][Full Text] [Related]
7. Type II phospholipase A2 in preterm human gestational tissues.
Lappas M; Permezel M; Georgiou HM; Rice GE
Placenta; 2001 Jan; 22(1):64-9. PubMed ID: 11162354
[TBL] [Abstract][Full Text] [Related]
8. Gestational tissue phospholipase A2 messenger RNA content and the onset of spontaneous labour in the human.
Aitken MA; Rice GE; Brennecke SP
Reprod Fertil Dev; 1990; 2(5):575-80. PubMed ID: 2075252
[TBL] [Abstract][Full Text] [Related]
9. Contribution of type II phospholipase A2 to in vitro phospholipase A2 enzymatic activity in human term placenta.
Rice GE; Wong MH; Farrugia W; Scott KF
J Endocrinol; 1998 Apr; 157(1):25-31. PubMed ID: 9614354
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical localization, messenger ribonucleic acid abundance, and activity of 15-hydroxyprostaglandin dehydrogenase in placenta and fetal membranes during term and preterm labor.
Sangha RK; Walton JC; Ensor CM; Tai HH; Challis JR
J Clin Endocrinol Metab; 1994 Apr; 78(4):982-9. PubMed ID: 8157731
[TBL] [Abstract][Full Text] [Related]
11. Expression of membrane prostaglandin E synthase in human placenta and fetal membranes and effect of labor.
Alfaidy N; Sun M; Challis JR; Gibb W
Endocrine; 2003 Apr; 20(3):219-25. PubMed ID: 12721500
[TBL] [Abstract][Full Text] [Related]
12. The expression of phospholipase A2 and lipocortins (annexins) I, II and V in human fetal membranes and placenta in association with labour.
Bennett P; Slater D; Berger L; Moor G
Prostaglandins; 1994 Aug; 48(2):81-90. PubMed ID: 7991777
[TBL] [Abstract][Full Text] [Related]
13. The expression of insulin-like growth factor (IGF) and IGF-binding protein (IGFBP) genes in the human placenta and membranes: evidence for IGF-IGFBP interactions at the feto-maternal interface.
Han VK; Bassett N; Walton J; Challis JR
J Clin Endocrinol Metab; 1996 Jul; 81(7):2680-93. PubMed ID: 8675597
[TBL] [Abstract][Full Text] [Related]
14. Type II phospholipase A2 in human gestational tissues: subcellular distribution of placental immuno- and catalytic activity.
Farrugia W; Aitken MA; van Dunné F; Wong MH; Brennecke SP; Scott KF; Rice GE
Biochim Biophys Acta; 1993 Feb; 1166(1):77-83. PubMed ID: 8431495
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemistry of carbonic anhydrase in human placenta and fetal membranes.
Mühlhauser J; Crescimanno C; Rajaniemi H; Parkkila S; Milovanov AP; Castellucci M; Kaufmann P
Histochemistry; 1994 Feb; 101(2):91-8. PubMed ID: 8071088
[TBL] [Abstract][Full Text] [Related]
16. Immunocytochemical distribution and localization of 15-hydroxyprostaglandin dehydrogenase in human fetal membranes, decidua, and placenta.
Cheung PY; Walton JC; Tai HH; Riley SC; Challis JR
Am J Obstet Gynecol; 1990 Nov; 163(5 Pt 1):1445-9. PubMed ID: 2240085
[TBL] [Abstract][Full Text] [Related]
17. Release of Type II phospholipase A2 immunoreactivity and phospholipase A2 enzymatic activity from human placenta.
Farrugia W; Rice GE; Wong MH; Scott KF; Brennecke SP
J Endocrinol; 1997 Apr; 153(1):151-7. PubMed ID: 9157179
[TBL] [Abstract][Full Text] [Related]
18. Relative abundance of human placental phospholipase A2 messenger RNA in late pregnancy.
Aitken MA; Rice G; Brennecke S
Prostaglandins; 1992 Apr; 43(4):361-70. PubMed ID: 1376934
[TBL] [Abstract][Full Text] [Related]
19. Expression of cytosolic and secreted forms of phospholipase A(2) and cyclooxygenases in human placenta, fetal membranes, and chorionic cell lines.
Johansen B; Rakkestad K; Balboa MA; Dennis EA
Prostaglandins Other Lipid Mediat; 2000 Mar; 60(4-6):119-25. PubMed ID: 10751642
[TBL] [Abstract][Full Text] [Related]
20. Secretory phospholipases and membrane polishing.
Rice GE
Placenta; 1998 Jan; 19(1):13-20. PubMed ID: 9481780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]